Introduction
Morphine is a very important drug, which is a powerful painkiller [1] .
Opiate dependence is caused by long-term consumption of these materials [2] . It has been illustrated that chronic use of opioid drugs could cause long-term changes in brain [3] . Regarding to the definition of American Society of Addiction Medicine Association, addiction is a chronic disease, making procedures such as joy, This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. reward, memory and incentives in brain [4] . The μ-opioid receptor of opiates is positioned in some areas of brain regulating feeling of pain like gray cortex, thalamus and cortex and the ventral tegmental area (VTA) and nucleus accumbens (NAc) regulating understanding of the joy and rewarding. Therefore, they could describe the reason of analgesic properties and joyful and euphoric properties created by opiates [5] . Dopaminergic neurons originated from the VTA area of neurons are sent to NAc and could be affected by rewards such as natural rewards like eating, sexual issues and several medicines.
Under such conditions, controlling the GABAergic interneurons in the VTA area is removed from the dopaminergic neurons and causes neural to shoot an increased level of extracellular dopamine in the NAc and as a result, punishment process is started [6] . The main neurotrophin brain-derived neurotrophic factor (BDNF) is the main neurotrophin in the brain, which could activate intracellular signaling through binding to its receptors, which is essential to neuronal survival, neuronal differentiation and regulation of learning and memory [7] . Moreover, BDNF plays a role in transcription and translation of proteins involved in several steps of synapse development and is also an underlying factor in the pathology of neural disease like Alzheimer's disease, schizophrenia and depression [8] . In opioid-depended individual, the serum level of BDNF is decreased [9] . Furthermore, in morphine-depended situation, BDNF gene exon is transcribed in low level. In these individuals, BDNF gene expression in the VTA is reduced [10] .
Cyclic AMP response element binding protein (CREB) is a central protein distributed in the whole body and its particular molecular mass is in average equal to 46 kDa. CREB is recognized as one of the transcription factors [11] . CREB helps control of cell growth steps such as proliferation, differentiation, survival and neural formation, learning and memory [12] . CREB regulated the expression of genes like BDNF and plays a key role in the mediation of response of neurotrophin [13] . As BDNF gene expression is regulated by CREB, decreased level of CREB could reduce BDNF level and hence, it might lead to damage of neural system due to the function of neurotrophins in the brain. Saffron contains numerous compounds such as 毩 -protein (a water-soluble carotenoid), crocins (including crocin, dicrocin, tricrosin, picrocrocin) [14] . It has been shown that saffron or its compounds (such as crocin) have various pharmacological properties such as antioxidant and neuroprotection [15] . Saffron could decrease sedimentation and accumulation of beta-amyloid in the brain [16] . Additionally, it has been shown that crocin has learning and memory space increase properties [17] . The moment it was mentioned, BDNF is an underlying factor for neural growth and CREF could regulate the gene transcription and may play a key role in important processes such as neural survival and regulation of cognitive processes such as memory space and learning. Consequently, decrease of BDNF and CREB gene expression could pave the way for neural disorders such as depressive disorder and Alzheimer. The main objective of this research was to investigate the effect of crocin carotenoid on BDNF and CREB gene expression in the brain VTA area and serum level of BDNF in morphine treat rats.
Materials and methods

Animals
In this study, 40 
The experimental groups
In this study, 5 different experimental groups (each group including 8 rats) were examined: 1) Non morphine remedied rats; 2) non morphine-treated rats + 25 mg/kg crocin; 3) morphine remedied rats (10 mg/kg); 4 and 5) morphine-treated rats + 12.5 and 25 mg/kg crocin, respectively.
Morphine and crocin injection
The rats were treated with morphine sulfate (10 mg/kg) with an interval of 12 h for 21 d, subcutaneously (s.c.). Morphine sulfate (Temad, Tehran, Iran) was dissolved in a volume of 10 mg/1 mL physiological saline before each injection. In the crocin treated groups, the crocin was injected in the form of intraperitoneal injections (i.p.) to 12.5 and 25 mg/kg per day at the beginning of the research to the end of a period for 21 d [18] . At the end of the study period (day 21), the rats were anesthetized (50 mg/kg ketamine and 4 mg/kg Xylasein, i.p. injection) and decapitated using the guillotine. 
Measurement of BDNF
The BDNF level in serum was measured by ELISA method and using ZellBio Kit (Germany) and based on the instruction of the manufacturing company.
Serum glucose, triglyceride and cholesterol level analysis
The serum fasting blood sugar (FBS), cholesterol and triglyceride were examinated using auto-analyzer device (KonE, Finland).
RNA extraction and complementary DNA (cDNA) synthesis
Total RNA extraction of cell was done on the tissue separated from VTA area using RNA Pars Tous Kit (Iran) according to its protocol.
RNA sample was dissolved in diethylpyrocarbonate-treated water and RNA measures were determined by an APEL PD-303UV spectrophotometer (Japan). The fidelity of extracted RNA was examined by electrophoresis 1% agarose and further staining with 
Real-Time PCR
To perform Real-Time PCR test, by using a reverse primer and a forward primer specified to particular BDNF and CREB genes as special genes and 毬 -actin gene as housekeeping gene (control), the synthesized cDNAs were determined by the referred genes and using SYBR PCR master mix (Takara) in the device, System
Step [21] . The primers in this study were designed using 
Results
Glucose, triglyceride and cholesterol serum level
In this study, glucose, triglyceride and cholesterol level in blood serum were measured in all experimental groups. As shown in Figure 1 , the serum glucose level in rats treated with morphine was enhanced significantly compared to control rats (P<0.001).
Treatment with 12.5 and 25 mg/kg of crocin could reduce the glucose level (dose-depended) in rats treated with morphine. This should be mentioned that the reduction was significant compared to the group treated with morphine (P<0.001) (Figure 1 ). The data in this study showed that treatment of rats with morphine could lead to a significant increase in serum cholesterol level compared to control group (P<0.01). Moreover, it was discovered that crocin treatment wasn't able to decrease the serum cholesterol in the group treated with morphine ( Figure 2) . The results obtained from this study showed that treatment of rats with morphine could cause a significant increase in serum triglyceride level compared to control group (P<0.01). Significant difference has not been discovered between group treated with morphine + crocin and group treated with morphine ( Figure 3 ). 
BDNF serum level
The BDNF protein level was measured using ELISA method. As illustrated in Figure 6 
Discussion
In this research, the effect of crocin on BDNF and CREB genes expression as well as BDNF serum level was studied in morphinetreated rats. Regarding to the obtained outcomes, treatment with morphine could lead to significant decrease of BDNF and CREB gene expression in the brain VTA area and decrease of BDNF serum level in comparison to control rats. Furthermore, the data showed that treatment with crocin at dose of 25 mg/kg could cause significant enhancement in BDNF and CREB gene expression in the brain VTA area as well as serum BDNF level in rats treated with morphine. It has been specified that there are a lot of μ-opioid receptor in the brain VTA area and their activation related to the rewarding effects of morphine [22] . In addition, previous researches have demonstrated that the addictive behaviors caused by morphine are depended on the activation of dopaminergic neurons in the brain VTA area. Therefore, reward response produced by activation of VTA-dopaminergic neurons by morphine could be one of the key factors of dependence on addictive substances [23, 24] . BDNF is recognized as a factor for brain growth, neural reconstruction and synapse plasticity [25] . BDNF receptors are plentifully available in the VTA-dopaminergic neurons [26] . BDNF might lead to survival and protection of dopamine neurons in the brain [27, 28] . In this field, it has been revealed that significant decrease of BDNF in the substantia nigra brain of Parkinson patients may lead to degeneration and destruction of these dopaminergic neurons [29] . Different studies have affirmed the effect of BDNF in learning, memory, identification, perception and regulation of various types of feelings. Moreover, BDNF disruption that can involve in many cognitive disorders such as schizophrenia, huntington, autism, depression, addiction and anxiety disorders has been studied [30, 31] . CREB is transcription factor activated in response to signaling routes such as calciumcalmodulin, growth factor and cytokines. Phosphorylation of CREB protein at ser133 by protein kinase A, MAP kinase and extracellular signal-regulated kinase could activate several gene transcription [32] .
One of the target genes of CREB is BDNF, which is responsible for regulating their gene expression [33] . Deactivation or decrease of CREB could reduce BDNF gene expression. In addition, the BDNF-TrkB signaling route could lead to activation of CREB through activating extracellular signal-regulated kinase and hence, the two factors could form a positive response loop [34] . The review conducted by Koo et al. on morphine-depended rats showed that, the BDNF gene expression level is significantly reduced in VTA area.
Furthermore, they discovered that the activity of CREB decreases in morphine-depended rats [35] . Yang et al. showed that chronic exposure of rat to morphine could decrease CREB phosphorylation level in the hippocampus area [36] . Zhou et al. demonstrated that morphine injection to rats can decrease CREB level in NAc [37] .
According to the outcomes of present research, chronic morphine treatment could cause significant reduction of CREB gene expression in the brain VTA area of male Wistar rats. Zhang et al. compared heroin-dependent people (an opioid derivative) with normal people and found that in heroin-dependent individuals, serum BDNF level was decreased compared to controls (P<0.01) [38] [46] . In the study of Razavi et al., in long term crocin treatment, a slight increase was observed in protein level of P-CREB, but it was not significant. It is concluded that antidepressant activity of crocin might be partially mediated by CREB [47] . In the present study, we showed that crocin could significantly increase BDNF and CREB gene expression in the brain VTA of morphine-treated rats.
Additionally, administration of crocin could elevate the serum BDNF level in morphine-treated animals significantly.
Altogether the results obtained from this study showed that chronic treatment of rats exposured to morphine could decrease expression of BDNF and CREB genes in the VTA area as well as serum BDNF level. Furthermore, the results obtained from this study showed that crocin administration with morphine could increase BDNF and CREB gene expression in the VTA area as well as serum BDNF level. The reduction of BDNF protein expression could lead to underlying difficulties and may lead to other species in the neural system. Hence, crocin as a complementary factor could be considered as remedying of morphine administration, side effects in opioid depended patients or the people treated with morphine for chronic period.
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